Current Assets
Bristol-Myers Squibb·Balance Sheet Statement·7 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | $26.9B | $28.1B | $29.8B | $30.8B | $33.2B | $35.6B | $29.4B | $27.2B |
| Cash and cash equivalents | $6.3B | $7.9B | $10.3B | $10.9B | $12.6B | $15.7B | $10.2B | $9.6B |
| Accounts receivable, net | $11.4B | $11B | $10.7B | $10.8B | $11.4B | $11.4B | $11.4B | $9.4B |
| Other current assets | $5.7B | $5.6B | $5.6B | $5.5B | $5.5B | $4.9B | $4.6B | $4.6B |
| Inventories | $3.1B | $3.3B | $2.6B | $2.7B | $2.7B | $2.8B | $2.7B | $2.8B |
| Available For Sale Securities Debt Securities Current | $360M | $204M | $513M | $907M | $1B | $776M | $464M | $912M |
| Short-term investments | $360M | $204M | $513M | $907M | $1B | $776M | $464M | $912M |